Cytogenetic assessment of methylphenidate treatment in pediatric patients treated for attention deficit hyperactivity disorder

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 677, Issue 1-2, 2009, Pages 53-58

  Tucker, James D ^a   Suter, Willi ^b   Petibone, Dayton M ^a   Thomas, Robert A ^a   Bailey, Nicole L ^a   Zhou, Yinong ^c   Zhao, Yanxing ^c   Muniz, Rafael ^c   Kumar, Vinod ^c  

^a WAYNE STATE UNIVERSITY   (United States)

^b Novartis Pharma AG   (Switzerland)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Attention deficit hyperactivity disorder; Children; Chromosomal aberrations; Methylphenidate; Micronuclei; Sister chromatid exchanges

Indexed keywords

METHYLPHENIDATE;

ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CHILD; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOGENETICS; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FEMALE; GROUPS BY AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICRONUCLEUS; PERIPHERAL LYMPHOCYTE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SISTER CHROMATID EXCHANGE;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR THERAPY; CHILD; CHROMOSOME ABERRATIONS; DNA DAMAGE; FEMALE; HUMANS; MALE; METHYLPHENIDATE; MICRONUCLEUS TESTS; MUTAGENS; SISTER CHROMATID EXCHANGE;

EID: 67650266246     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2009.05.005     Document Type: Article

References (15)

1. Robison L.M., Sclar D.A., Skaer T.L., and Galin R.S. Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder: 1995-99. Int. Clin. Psychopharmacol. 19 (2004) 17-22
2. El-Zein R.A., Abdel-Rahman S.Z., Hay M.J., Lopez M.S., Bondy M.L., Morris D.L., and Legator M.S. Cytogenetic effects in children treated with methylphenidate. Cancer Lett. 230 (2005) 284-291
3. Preston R.J., Kollins S.H., Swanson J.M., Greenhill L.L., Wigal T., Elliott G.R., and Vitiello B. Comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al. Cancer Lett. 230 (2005) 292-294
4. Jacobson-Kram D., Mattison D., Shelby M., Slikker W., Tice R., and Witt K. Methylphenidate and chromosome damage. Cancer Lett. 260 (2008) 216-218
5. Bonassi S., Norppa H., Ceppi M., Stromberg U., Vermeulen R., Znaor A., Cebulska-Wasilewska A., Fabianova E., Fucic A., Gundy S., Hansteen I.L., Knudsen L.E., Lazutka J., Rossner P., Sram R.J., and Boffetta P. Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22 358 subjects in 11 countries. Carcinogenesis 29 (2008) 1178-1183
6. Murgia E., Ballardin M., Bonassi S., Rossi A.M., and Barale R. Validation of micronuclei frequency in peripheral blood lymphocytes as early cancer risk biomarker in a nested case-control study. Mutat. Res. 639 (2008) 27-34
7. Manjanatha M.G., Shelton S.D., Dobrovolsky V.N., Shaddock J.G., McGarrity L.G., Doerge D.R., Twaddle N.W., Lin C.J., Chen J.J., Mattison D.R., and Morris S.M. Pharmacokinetics, dose-range, and mutagenicity studies of methylphenidate hydrochloride in B6C3F1 mice. Environ. Mol. Mutagen. 49 (2008) 585-593
8. Suter W., Martus H.J., and Elhajouji A. Methylphenidate is not clastogenic in cultured human lymphocytes and in the mouse bone-marrow micronucleus test. Mutat. Res. 607 (2006) 153-159
9. Walitza S., Werner B., Romanos M., Warnke A., Gerlach M., and Stopper H. Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder?. Environ. Health Perspect. 115 (2007) 936-940
10. Morris S.M., Dobrovolsky V.N., Shaddock J.G., Mittelstaedt R.A., Bishop M.E., Manjanatha M.G., Shelton S.D., Doerge D.R., Twaddle N.C., Chen J.J., Lin C.J., Paule M.G., Slikker Jr. W., Hotchkiss C.E., Petibone D., Tucker J.D., and Mattison D.R. The genetic toxicology of methylphenidate hydrochloride in non-human primates. Mutat. Res. 673 (2009) 59-66
11. Andreazza A.C., Frey B.N., Valvassori S.S., Zanotto C., Gomes K.M., Comim C.M., Cassini C., Stertz L., Ribeiro L.C., Quevedo J., Kapczinski F., Berk M., and Goncalves C.A. DNA damage in rats after treatment with methylphenidate. Prog. Neuropsychopharmacol. Biol. Psychiatry 31 (2007) 1282-1288
12. Martins M.R., Reinke A., Petronilho F.C., Gomes K.M., Dal-Pizzol F., and Quevedo J. Methylphenidate treatment induces oxidative stress in young rat brain. Brain Res. 1078 (2006) 189-197
13. Witt K.L., Shelby M.D., Itchon-Ramos N., Faircloth M., Kissling G.E., Chrisman A.K., Ravi H., Murli H., Mattison D.R., and Kollins S.H. Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD. J. Am. Acad. Child Adolesc. Psychiatry 47 (2008) 1375-1383
14. Stopper H., Walitza S., Warnke A., and Gerlach M. Brief review of available evidence concerning the potential induction of genomic damage by methylphenidate. J. Neural. Transm. 115 (2008) 331-334
15. Oestreicher N., Friedman G.D., Jiang S.F., Chan J., Quesenberry Jr. C., and Habel L.A. Methylphenidate use in children and risk of cancer at 18 sites: results of surveillance analyses. Pharmacoepidemiol. Drug Saf. 16 (2007) 1268-1272